About us
Products
R&D Activity
Business development
News
Contact us
About NMN
Company profile
Word from our CEO
R&D Center and Cooperative business
APIs of Cephalosporins
APIs Intermediate of Cephalosporins
APIs of Penicillins
Other Intermediates
Possible CRO and CMO
Other Products(CRO/CMO)
Key Items
CRO
CMO
API & Raw material sourcing
Import & Export
ß-Nicotinamide Mononucleotide, NMN
NMN finished product solution
Formulation of NMN
Populra Science of NMN
The history of NMN
NMN's Mechanism
How NMN enters Cell
Safty of NMN
Research of NMN
Prospect of NMN
Tel：+86-(0)530-5585135
E-mail：
letsgo21c@alliancepharmalab.com letsgo21c@sdhtrade.com
[详细]
Home
>
NEWS
> Text
NEWS
Activity in API Xiamen China
UpdateTime:[2017-11-23 15:40:57]
article entry:
viewed：[6510]
size
previous：
Activity in CPHI Frankfurt
next：
Participate in Pharmaconex Egypt 2018
reading
Key items
[2021-10-27]
Beta Nicotinamide mononucleotide
[2021-10-28]
Participate in Pharmaconex Egypt 2018
[2018-05-15]
Activity in API Xiamen China
[2017-11-23]
Activity in CPHI Frankfurt
[2017-11-03]
